Markets:

Overview

News

Currencies

International

Treasuries

Boston Scientific (NY:BSX)

43.44 -0.67 (-1.53%)

Streaming Delayed Price Updated: 12:10 PM EDT, Sep 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

30 31 Next >

Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review ↗

April 26, 2024

Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser.

Via Investor's Business Daily

Top 4 Health Care Stocks That May Plunge This Month ↗

April 26, 2024

Via Benzinga

Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating ↗

April 25, 2024

On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier.

Via Investor's Business Daily

(BSX) - Analyzing Boston Scientific's Short Interest ↗

April 25, 2024

Via Benzinga

Key Takeaways From Boston Scientific Analyst Ratings ↗

April 25, 2024

Via Benzinga

Unveiling 13 Analyst Insights On Boston Scientific ↗

April 03, 2024

Via Benzinga

Looking Into Boston Scientific's Recent Short Interest ↗

April 02, 2024

Via Benzinga

Wabtec Rumbles onto Stock Spotlight List. Check These Lists For Best Stocks To Watch And Buy ↗

April 24, 2024

Wabtec leads a diverse group climbing aboard the Stock Spotlight list, including defense and aerospace play TransDigm.

Via Investor's Business Daily

Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 24, 2024

Via Benzinga

Boston Scientific Lifts 2024 Profit Forecast On Strong Growth From Cardiovascular Devices, Stock Soars ↗

April 24, 2024

Boston Scientific reports impressive Q1 earnings, with revenues of $3.86 billion, beating estimates. Cardiovascular segment leads with $2.4 billion sales, up 15.9%. Outlook: 2024 net sales growth...

Via Benzinga

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $8,100 Today ↗

March 28, 2024

Via Benzinga

NYSE:BSX may be ready to breakout. ↗

March 11, 2024

Will BOSTON SCIENTIFIC CORP breakout?

Via Chartmill

$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,200 Today ↗

March 08, 2024

Via Benzinga

Treasury Yields Rise, Tesla Jumps On Cheaper Model Pledge, Yen Plummets To 34-Year Lows: What's Driving Markets Wednesday? ↗

April 24, 2024

Rising Treasury yields have investors cautious despite positive news from the earnings season. The yield on the long-dated 30-year Treasury bond has surged to 4.79%. It’s on track to close at the...

Via Benzinga

Topics Bonds

Hilton Worldwide Reports Upbeat Results, Joins Hasbro, Vertiv Holdings And Other Big Stocks Moving Higher On Wednesday ↗

April 24, 2024

Via Benzinga

17 Analysts Have This To Say About Boston Scientific ↗

March 07, 2024

Via Benzinga

BSX Stock Earnings: Boston Scientific Beats EPS, Beats Revenue for Q1 2024 ↗

April 24, 2024

BSX stock results show that Boston Scientific beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Boston Scientific Pops Into Buy Zones On Solid First-Quarter Report ↗

April 24, 2024

Boston Scientific heads for two different buy zones after topping Q1 views and hoisting guidance above expectations.

Via Investor's Business Daily

Nasdaq Futures Get A Lift From Tesla, Texas Instruments Earnings: Analyst Points To Key Catalyst For Boosting Rally ↗

April 24, 2024

Nasdaq and S&P 500 futures signaled a higher open on Wednesday, thanks to upbeat guidance from EV giant Tesla, Inc. (NASDAQ:TSLA) and semiconductor m

Via Benzinga

FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious' ↗

April 18, 2024

Boston Scientific announces a Class I recall of Obsidio Embolic due to high-risk implications for lower GI bleeding embolization. Potential adverse effects include bowel ischemia, necessitating major...

Via Benzinga

Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week ↗

April 21, 2024

Corporate profit growth rose in Q3 2023 and is expected to continue in Q1.

Via Benzinga

Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years ↗

April 16, 2024

Via Benzinga

Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA ↗

April 15, 2024

BofA Securities' upgrades Integer, highlighting the growth potential of pulsed field ablation (PFA) in atrial fibrillation treatment. With projections of PFA sales skyrocketing from $100-200 million in...

Via Benzinga

Topics Supply Chain

5 Things to Know in Investing This Week ↗

April 03, 2024

The Shockwave Issue

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

March 29, 2024

Via Benzinga

Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst ↗

March 27, 2024

Johnson & Johnson reportedly in talks to acquire Shockwave Medical. Potential acquisition aligns with J&J's interest in expanding into cardiovascular devices. Piper Sandler considers J&J a potential...

Via Benzinga

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

March 22, 2024

A look at five stocks that are seeing increased attention from investors and Benzinga readers. The list includes several large cap stocks for the week.

Via Benzinga

Why Abbott's Formula-Related Sell-Off Could Be A Buying Opportunity, Says Analyst ↗

March 15, 2024

Fellow infant formula maker Reckitt Benckiser was ordered to pay $60 million to a mother whose baby died after eating Enfamil.

Via Investor's Business Daily

Topics Death

Tandem Diabetes Care Stock Belongs On Your Watchlist As RS Rating Jump Higher ↗

March 11, 2024

On Monday, Tandem Diabetes Care stock received an upgrade to its Relative Strength (RS) Rating, from 68 to 78.

Via Investor's Business Daily

The Hot List: 3 AI Stocks Worth Buying on Weakness ↗

March 01, 2024

Firms using AI directly can be great picks for long-term investors, such as these three AI stocks to buy on weakness.

Via InvestorPlace

Topics Artificial Intelligence

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

30 31 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.